| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |